Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Rosuvastatin safety: lessons from the FDA review and post-approval surveillance.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Rosuvastatin safety: lessons from the FDA review and post-approval surveillance.
Rosuvastatin safety: lessons from the FDA review and post-approval surveillance. Expert Opin Drug Saf. 2004 Nov; 3(6):547-57.
View in:
PubMed
subject areas
Acute Kidney Injury
Adverse Drug Reaction Reporting Systems
Biomarkers
Cholesterol, LDL
Creatine Kinase
Creatine Kinase, MM Form
Drug Approval
Fluorobenzenes
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hyperlipidemias
Incidence
Isoenzymes
Kidney Tubules
Muscular Diseases
Product Surveillance, Postmarketing
Proteinuria
Pyridines
Pyrimidines
Rhabdomyolysis
Rosuvastatin Calcium
Sulfonamides
authors with profiles
Michael H. Davidson